Payments made 11 days late

Payments were made 11 days beyond the agreed credit period in January, on average, up from 10 days in December, Business Data Israel said Tuesday.

By DANIEL KENNEMER
February 1, 2006 07:07

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

Payments were made 11 days beyond the agreed credit period in January, on average, up from 10 days in December, Business Data Israel said Tuesday. Average actual credit extended in business sector payments rose to 100 days in January, from 99 in December, as agreed business days remained stable at 89. The worse payment norms were seen in transportation and moving services, with payments made 42 days beyond the agreed date, followed by the print industry - including newspapers and publishing houses - where payments lagged 39 days. In paper product manufacturing and wholesaling, on the other hand, payments were made only six days late, on average.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS